Preface

Over the past two decades, the outcome of multiple myeloma patients has substantially improved due to the introduction of several lines of novel therapies, the adoption of new therapeutic strategies, an increased understanding of disease biology, and recent advances in diagnostics and supportive care.

This book is a recent update on multiple myeloma. It is divided into three sections that cover a wide variety of topics, including diagnosis, risk stratification, and management of multiple myeloma; treatment of myeloma at diagnosis and at relapse; management of renal failure in patients with multiple myeloma; and stem cell therapies in multiple myeloma. Each chapter is written by clinicians and scientists with expertise in the field.

I would like to thank the authors for their valuable contributions, as well as Publishing Manager Paula Gavran and the staff at IntechOpen for their remarkable efforts throughout the publication process.

> **Khalid Ahmed Al-Anazi** Department of Adult Hematology and Hematopoietic Stem Cell Transplantation, Oncology Center, King Fahad Specialist Hospital, Dammam, Saudi Arabia

**1**

Section 1

Update on Diagnosis,

Prognosis and Treatment

of Multiple Myeloma

### Section 1
